Salvatore Corrao

About

full professor of internal medicine 2022

Employment

• Universita' degli Studi di Palermo Docenti di ruolo di IIa fascia
  2019 - Present
• Universita' degli Studi di Palermo Docenti di ruolo di IIa fascia
  2013 - 2018
• Universita' degli Studi di Palermo Docenti di ruolo di IIa fascia
  2013 - 2018
• Universita' degli Studi di Palermo Docenti di ruolo di IIa fascia
  2008 - 2012
• Universita' degli Studi di Palermo Docenti di ruolo di IIa fascia
  2008 - 2012

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (409)

• Exercise as targeted therapy in type 2 diabetes: a phenotype-informed clinical prioritisation framework for adapted physical activity
  Diabetes Research and Clinical Practice 2026 DOI: 10.1016/j.diabres.2026.113384
  +Save
• Cockcroft–Gault in Contemporary Clinical Trials
  Journal of the American Society of Nephrology 2026 DOI: 10.1681/ASN.0000001233
  +Save
• SURPASS‐CVOT and the Emerging Biology of Cardiometabolic Benefit
  Diabetes, Obesity and Metabolism 2026 DOI: 10.1111/dom.71175
  +Save
• The challenge of integrating artificial intelligence into clinical reasoning by augmenting the physician’s central cognitive role
  QJM: An International Journal of Medicine 2026 DOI: 10.1093/qjmed/hcag192
  +Save
• The end of the primary–secondary prevention dichotomy in high-risk diabetes? Lessons from VESALIUS-CV
  Acta Diabetologica 2026 DOI: 10.1007/s00592-026-02748-8
  +Save
• Disrupting the adiposopathy-inflammation loop: a translational immunometabolic framework for inflammatory disease
  Journal of Translational Medicine 2026 DOI: 10.1186/s12967-026-08564-6
  +Save
• Palmitoylethanolamide/Baicalin Supplementation and Changes in Pain and Sudomotor Function in Type 2 Diabetes: A Retrospective Matched Real-World Cohort Study
  Nutrients 2026 DOI: 10.3390/nu18121894
  +Save
• Comment on Sattar et al. Weight Reduction With Tirzepatide Varied Meaningfully by Baseline HbA1c Category in Adults With Overweight or Obesity and Type 2 Diabetes in SURMOUNT-2. Diabetes Care 2025;48:e136–e137
  Diabetes Care 2026 DOI: 10.2337/dc25-2212
  +Save
• Adaptive evidence-based medicine in type 2 diabetes: beyond the average effect toward personalised clinical decision-making for a humanised medicine
  Diabetes Research and Clinical Practice 2026 DOI: 10.1016/j.diabres.2026.113243
  +Save
• Risk of biliary diseases in patients with type 2 diabetes or obesity treated with tirzepatide: A critical appraisal
  Journal of Diabetes Investigation 2026 DOI: 10.1111/jdi.70298
  +Save